Table 2.
Examination of correlation between clinical data and immunohistochemical scores
| Variables | All cases N=45 |
B-catenin IS |
p value | All cases N=30 |
CD133 IS | p value | ||
| (%) | 0-2 | ≥3 | (%) | 0-2 | ≥3 | |||
| Gender | 0.4917 | 1.0000 | ||||||
| Males | 30 (67) | 20 (62.5) | 10 (77) | 21 (70) | 15 (71) | 6 (67) | ||
| Females | 15 (33) | 12 (37.5) | 3 (23) | 9 (30) | 6 (29) | 3 (33) | ||
| Age | 0.4113 | 1.0000 | ||||||
| ≤18 y | 9 (20) | 5 (16) | 4 (31) | 9 (30) | 6 (29) | 3 (33) | ||
| >18 y | 36 (80) | 27 (84) | 9 (69) | 21 (70) | 15 (71) | 6 (67) | ||
| Histotype | 0.0895 | 0.1432 | ||||||
| adaCP | 38 (84) | 25 (78) | 13 (100) | 25 (83) | 19 (90) | 6 (67) | ||
| papCP | 7 (16) | 7 (22) | 0 (0) | 5 (17) | 2 (10) | 3 (33) | ||
| Recurrence | 0.0039 | 0.1232 | ||||||
| Yes | 13 (29) | 5 (16) | 8 (62) | 13 (43) | 7 (33) | 6 (67) | ||
| No | 32 (71) | 27 (84) | 5 (38) | 17 (57) | 14 (67) | 3 (33) | ||
| Variables | All cases N=31 |
CD166 IS |
p value | All cases N=41 |
Ki67 L.I. | p value | ||
| (%) | 0-2 | ≥3 | (%) | 0-2 | ≥3 | |||
| Gender | 1.0000 | 0.4926 | ||||||
| Males | 21 (68) | 11 (65) | 10 (71) | 29 (71) | 12 (63) | 17 (77) | ||
| Females | 10 (32) | 6 (35) | 4 (29) | 12 (29) | 7 (37) | 5 (23) | ||
| Age | 0.6927 | 1.0000 | ||||||
| ≤18 y | 9 (29) | 4 (31) | 5 (36) | 7 (17) | 3 (16) | 4 (18) | ||
| >18 y | 22 (71) | 13 (69) | 9 (64) | 34 (83) | 16 (84) | 18 (82) | ||
| Histotype | 0.6358 | 0.6681 | ||||||
| adaCP | 26 (84) | 15 (88) | 11 (79) | 35 (85) | 17 (89) | 18 (81) | ||
| papCP | 5 (16) | 2 (12) | 3 (21) | 6 (15) | 2 (11) | 4 (19) | ||
| Recurrence | 0.0040 | 0.0385 | ||||||
| Yes | 13 (42) | 3 (76) | 10 (71) | 11 (27) | 2 (10) | 9 (41) | ||
| No | 18 (58) | 14 (24) | 4 (29) | 30 (73) | 17 (90) | 13(59) | ||
All statistcally significant findings were highlighted with bold